Sommaire

Numéro précédent | Numéro suivant

• • ·Two days in New York: reflections on the UN NCD summit

    Page :981

     
• • ·Intraoperative MRI in glioma surgery: proof of benefit?

    Page :982-983

    Christopher Nimsky

     
• • ·Hope without hype: EML4-ALK inhibition for treatment of lung cancer

    Page :983-984

    Ramaswamy Govindan

     
• • ·Rituximab in DLBCL: 6 years on

    Page :984-985

    Fernando Cabanillas

     
• • ·Loops in the natural history of cervical cancer

    Page :986

    Karl Ulrich Petry

     
• • ·Sequential chemotherapy for colorectal cancer

    Page :987-988

    Matthew Seymour

     
• • ·Eribulin in soft-tissue sarcomas

    Page :988-989

    Robert G Maki

     
• • ·Erratum

    Page :989

    
• • ·SLN mapping in colorectal cancer

    Page :990

    Oddmund Nordgård, Rune Smaaland

    
• • ·SLN mapping in colorectal cancer – Authors’ reply

    Page :990-991

    Martijn HGM van der Pas, Sybren Meijer, Wilhelmus JHJ Meijerink

    
• • ·Zoledronic acid in early-stage breast cancer

    Page :991

    Nicola Normanno, Antonella De Luca, Marianna Gallo, Luana Lamura, Francesco Perrone

     
• • ·Adjuvant zoledronic acid for breast cancer: mechanism of action?

    Page :991-992

    Volker Kunzmann, Martin Wilhelm

     
• • ·Premature conclusions on HPV-only testing

    Page :992-993

    Jianyu Rao, Mary Levin, Chengquan Zhao

    
• • ·Premature conclusions on HPV-only testing – Authors’ reply

    Page :993

    Hormuzd A Katki, Walter K Kinney, Barbara Fetterman, Thomas Lorey, Nancy E Poitras, Li Cheung, Franklin Demuth, Mark Schiffman, Sholom Wacholder, Philip E Castle

    
• • ·Donor conception and sharing of genetic information

    Page :994

    Talha Burki

     
• • ·Cannabis, a new option for chronic cancer pain?

    Page :995

    Tim Dehnel

     
• • ·Exposure to chemotherapy is an occupational hazard

    Page :995

    Jill Jouret

    
• • ·Antioxidants and cancer

    Page :996

    Justin Stebbing, Colin A Hart

     
• • ·Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial

    Page :997-1003

    Christian Senft, Andrea Bink, Kea Franz, Hartmut Vatter, Thomas Gasser, Volker Seifert

    Résumé Résumé Plan Plan   
• • ·Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis

    Page :1004-1012

    Alice T Shaw, Beow Y Yeap, Benjamin J Solomon, Gregory J Riely, Justin Gainor, Jeffrey A Engelman, Geoffrey I Shapiro, Daniel B Costa, Sai-Hong I Ou, Mohit Butaney, Ravi Salgia, Robert G Maki, Marileila Varella-Garcia, Robert C Doebele, Yung-Jue Bang, Kimary Kulig, Paulina Selaru, Yiyun Tang, Keith D Wilner, Eunice L Kwak, Jeffrey W Clark, A John Iafrate, D Ross Camidge

    Résumé Résumé Plan Plan   
• • ·CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group

    Page :1013-1022

    Michael Pfreundschuh, Evelyn Kuhnt, Lorenz Trümper, Anders Österborg, Marek Trneny, Lois Shepherd, Devinder S Gill, Jan Walewski, Ruth Pettengell, Ulrich Jaeger, Pier-Luigi Zinzani, Ofer Shpilberg, Stein Kvaloy, Peter de Nully Brown, Rolf Stahel, Noel Milpied, Armando López-Guillermo, Viola Poeschel, Sandra Grass, Markus Loeffler, Niels Murawski, for the MabThera International Trial (MInT) Group ‡

    Résumé Résumé Plan Plan   
• • ·Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies

    Page :1023-1031

    Xavier Castellsagué, Mireia Díaz, Salvatore Vaccarella, Silvia de Sanjosé, Nubia Muñoz, Rolando Herrero, Silvia Franceschi, Chris J L M Meijer, F Xavier Bosch

    Résumé Résumé Plan Plan   
• • ·Sequential versus combination chemotherapy for the treatment of advanced colorectal cancer (FFCD 2000–05): an open-label, randomised, phase 3 trial

    Page :1032-1044

    Michel Ducreux, David Malka, Jean Mendiboure, Pierre-Luc Etienne, Patrick Texereau, Dominique Auby, Philippe Rougier, Mohamed Gasmi, Marine Castaing, Moncef Abbas, Pierre Michel, Dany Gargot, Ahmed Azzedine, Catherine Lombard-Bohas, Patrick Geoffroy, Bernard Denis, Jean-Pierre Pignon, Laurent Bedenne, Olivier Bouché, for the Fédération Francophone de Cancérologie Digestive (FFCD) 2000–05 Collaborative Group ‡

    Résumé Résumé Plan Plan   
• • ·Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes

    Page :1045-1052

    Patrick Schöffski, Isabelle Laure Ray-Coquard, Angela Cioffi, Nguyen Bin Bui, Sebastian Bauer, Joerg Thomas Hartmann, Anders Krarup-Hansen, Viktor Grünwald, Raf Sciot, Herlinde Dumez, Jean-Yves Blay, Axel Le Cesne, Jantien Wanders, Carolyn Hayward, Sandrine Marreaud, Monia Ouali, Peter Hohenberger, for the European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG)

    Résumé Résumé Plan Plan  
• • ·Efficacy and safety of palliative chemotherapy for patients with advanced breast cancer pretreated with anthracyclines and taxanes: a systematic review

    Page :1053-1061

    Linda JM Oostendorp, Peep FM Stalmeier, A Rogier T Donders, Winette TA van der Graaf, Petronella B Ottevanger

    Résumé Résumé Plan Plan  
• • ·Intraoperative MRI-guided resection of glioblastoma multiforme: a systematic review

    Page :1062-1070

    Pieter L Kubben, Karlien J ter Meulen, Olaf EMG Schijns, Mariël P ter Laak-Poort, Jacobus J van Overbeeke, Henk van Santbrink

    Résumé Résumé Plan Plan   
• • ·Mucinous carcinomas of the ovary and colorectum: different organ, same dilemma

    Page :1071-1080

    Linda E Kelemen, Martin Köbel

    Résumé Résumé Plan Plan